Merit Medical Systems, Inc. $MMSI Shares Bought by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky grew its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 22.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,222 shares of the medical instruments supplier’s stock after acquiring an additional 7,753 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Merit Medical Systems were worth $3,514,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. CI Investments Inc. increased its stake in Merit Medical Systems by 18.5% in the 3rd quarter. CI Investments Inc. now owns 30,325 shares of the medical instruments supplier’s stock valued at $2,524,000 after purchasing an additional 4,737 shares in the last quarter. Fisher Asset Management LLC increased its position in shares of Merit Medical Systems by 2.9% in the third quarter. Fisher Asset Management LLC now owns 221,609 shares of the medical instruments supplier’s stock valued at $18,445,000 after buying an additional 6,164 shares in the last quarter. William Blair Investment Management LLC increased its position in shares of Merit Medical Systems by 16.8% in the third quarter. William Blair Investment Management LLC now owns 863,996 shares of the medical instruments supplier’s stock valued at $71,910,000 after buying an additional 124,396 shares in the last quarter. Quantbot Technologies LP boosted its position in shares of Merit Medical Systems by 130.6% in the 3rd quarter. Quantbot Technologies LP now owns 14,426 shares of the medical instruments supplier’s stock worth $1,201,000 after buying an additional 8,170 shares in the last quarter. Finally, Handelsbanken Fonder AB boosted its position in shares of Merit Medical Systems by 42.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 321,309 shares of the medical instruments supplier’s stock worth $26,743,000 after buying an additional 95,000 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Needham & Company LLC cut their target price on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a research report on Wednesday, February 25th. Piper Sandler cut their price objective on Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Wells Fargo & Company cut Merit Medical Systems from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $95.00 to $78.00 in a report on Thursday, February 26th. Robert W. Baird set a $108.00 price target on Merit Medical Systems in a research report on Tuesday, December 16th. Finally, Barrington Research raised their price target on Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus target price of $103.33.

Merit Medical Systems Price Performance

Merit Medical Systems stock opened at $74.16 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34. The company has a market cap of $4.41 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 2.17 and a beta of 0.62. Merit Medical Systems, Inc. has a 1 year low of $73.60 and a 1 year high of $107.27. The firm has a 50 day moving average price of $82.77 and a 200 day moving average price of $84.63.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.08. The company had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.